Greater Tokyo Biocommunity (GTB): Collaboration Among the University of Tokyo, Tokyo Medical and Dental University, and the JPMA at the Hongo, Ochanomizu, and Tokyo Station Area Hub

Printable PDF

October 12, 2022
The University of Tokyo
Tokyo Medical and Dental University
Japan Pharmaceutical Manufacturers Association

We are pleased to announce the launch of a promotional framework at the Greater Tokyo Biocommunity (GTB) “Hongo, Ochanomizu, and Tokyo Station Area Hub,” with the University of Tokyo, Tokyo Medical and Dental University, and the Japan Pharmaceutical Manufacturers Association (JPMA) serving as the coordinating organizations.

Established and launched in November 2021, GTB is a global biocommunity aimed at strengthening the “bio-industry ecosystem” in the Tokyo metropolitan area to contribute to achieving the goal set forth in the government’s “Bio Strategy 2020”: “Realizing the world’s most advanced bioeconomy society by 2030.”

This promotion framework will operate at the GTB’s “Hongo, Ochanomizu, and Tokyo Station Area Hubs”—the primary activity areas for the University of Tokyo and Tokyo Medical and Dental University—and will provide functions for promoting industry-academia collaboration, incubation, networking, human resource development, and funding,hospital and clinical research functions, along with the JPMA—an organization of pharmaceutical companies with capabilities in clinical development and production aimed at commercializing research findings—will serve as the core of this framework, driving the hub’s activities. Furthermore, by broadly inviting universities and research institutions,hospitals, government-affiliated agencies, venture capital firms, startup support organizations, and private companies based in this area to participate widely. By collaborating organically with these members, we will build a value chain that seamlessly connects the process from invention and discovery (creation of seeds) to commercialization and production, thereby providing attractive products and services.

The University of Tokyo, Tokyo Medical and Dental University, and the JPMA will fulfill their respective missions while mutually leveraging their unique functions and knowledge to form an ecosystem that attracts talent and investment from around the world, and will work toward fostering innovation.

Additionally, a session on the GTB Hongo, Ochanomizu, and Tokyo Station area is scheduled for October 13, 2022, at “BioJapan 2022” ( https://jcd-expo.jp/ja/ ). We plan to present the future plans for this hub during the session.

From left: Yasufumi Okada, Chairman of the JPMA; Yujiro Tanaka, President of Tokyo Medical and Dental University;
Teruo Fujii, President of the University of Tokyo; and Yoshiaki Tsukamoto, Executive Director of the Japan Bioindustry Association
About Greater Tokyo Biocommunity (GTB)
GTB is an organization that promotes the establishment of a global bio-community hub to strengthen the bio-industry ecosystem and achieve the goal set forth in the national “Bio Strategy 2020” of “realizing the world’s most advanced bioeconomy society by 2030.” A total of 45 entities (as of October 1)—including local governments, universities, and research institutes related to the bio-industry, primarily in the Tokyo metropolitan area,bio-related organizations, industrial support agencies, and financial and investment institutions—all centered in the Tokyo metropolitan area—have endorsed the above objectives and are participating in the initiative. The secretariat is managed by the Bioindustry Association, a general incorporated foundation.

Back to 2022 News Releases

TOP